Dr. Gregory E. Cooper, MD

Dr. Cooper practices at Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky.

Dr. Cooper's NPI, 1265466627, was assigned on July 10, 2006. Dr. Cooper graduated from University of Kentucky College of Medicine in 1994. Dr. Cooper holds Kentucky license 36163.

Dr. Cooper's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD, at 4960 Norton Healthcare Blvd, Louisville, KY 40241.

Dr. Cooper's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky. Dr. Cooper is also affiliated with Norton Hospital. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Cooper to 1 more hospital, 2 medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cooper is licensed in Kentucky.

CMS data shows 538 Medicare services from Dr. Cooper across 6 procedure codes in 2024, for 398 Medicare patients. Medicare paid $49,877 for them. Every service was in an office.

CMS counts 398 Medicare patients who saw Dr. Cooper in 2024. The largest group is 75 to 84, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 77, with 58% women.

In 2024, Dr. Cooper wrote 2,696 Medicare Part D claims for 531 patients. 99% of them were for generic drugs. CMS names the drug for 2,595 of them, across 16 drugs with 11 or more claims each, at $57,092 in total drug cost. In 2023, CMS named 2,459 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Cooper for performance year 2024, reported as part of a group. Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cooper as offering telehealth.

Dmand AI links 14 papers to Dr. Cooper, published from 2011 to 2024. 2011 was the busiest year, with 2. The most frequent topics are Alzheimer Disease, Cognitive Dysfunction and Dementia. Dr. Cooper has published most often in J Alzheimers Dis. Dr. Cooper's most frequent co-authors are Gregory Alexander Jicha, MD, Christopher B. Shields, MD and Nancy J. Stiles, MD.

Dmand AI links Dr. Cooper to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Delirium. Open Payments lists research payments to Dr. Cooper that name 2 trials.

CMS Open Payments shows 635 general payments to Dr. Cooper from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Eli Lilly and Company paid the most, $1,475. It also lists 7 research payments totaling $41,494 from 2016 to 2023, naming 2 clinical trials.

Dr. Cooper graduated from University of Kentucky College of Medicine in 1994.